These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2332771)

  • 1. Immunosuppressive effects of pentostatin.
    Kraut EH; Neff JC; Bouroncle BA; Gochnour D; Grever MR
    J Clin Oncol; 1990 May; 8(5):848-55. PubMed ID: 2332771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
    Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
    Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
    Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
    Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia.
    Ho AD; Männel DN; Wulf G; Kirchner H; Gundt A; Trede I; Rensch K; Hunstein W
    Leukemia; 1990 Aug; 4(8):584-9. PubMed ID: 1697012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with 2'-deoxycoformycin.
    Catovsky D
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S103-7. PubMed ID: 9137963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
    Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
    J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
    Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
    Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
    Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
    Nagai T; Izumi T; Noborio K; Takatoku M; Ohtsuki T; Machii T; Komatsu N; Ozawa K
    Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
    Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
    Br J Haematol; 1992 Feb; 80(2):194-8. PubMed ID: 1550776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
    J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.